A 72-year-old man with nonhealing facial erosions and bullae

Catherina X Pan; Catherine E Pisano; Mia S DeSimone; Vinod E Nambudiri

doi:10.1016/j.jdcr.2022.06.026

A 72-year-old man with nonhealing facial erosions and bullae

JAAD Case Rep. 2022 Jul 20:27:99-102. doi: 10.1016/j.jdcr.2022.06.026. eCollection 2022 Sep.

Authors

Catherina X Pan^{1

2}, Catherine E Pisano^{1

2

3}, Mia S DeSimone⁴, Vinod E Nambudiri^{1

2

3}

Affiliations

¹ Harvard Medical School, Boston, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Dana-Farber Cancer Institute, Cutaneous Oncology, Boston, Massachusetts.
⁴ Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.

No abstract available

Keywords: BP, bullous pemphigoid; C3, complement component 3; DIF, direct immunofluorescence; ICI, immune checkpoint inhibitor; ICI-BP, immune checkpoint inhibitor–induced bullous pemphigoid; PV, pemphigus vulgaris; autoimmune disease; bullous pemphigoid; immune checkpoint inhibitor; immune checkpoint inhibitor–induced bullous pemphigoid; immune-related adverse event; radiation therapy.